HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Malignant neoplasm of soft tissue — Clinical Guidelines

Overview

Malignant neoplasms of soft tissue encompass a diverse group of tumors arising from mesenchymal tissues, often requiring precise diagnostic evaluation and tailored management strategies to address both local effects and systemic implications. 2

Diagnosis

Morphologic Evaluation: Initial diagnosis often relies on histopathological examination.

Immunohistochemistry: Essential for distinguishing between morphologically similar lesions; frequently used with panels of markers. 2

Molecular Techniques: Increasingly integrated into routine diagnostics to detect genetic and cytogenetic abnormalities, complementing immunohistochemical findings. 2

Imaging: MRI and CT scans crucial for tumor staging and assessing extent of disease.

Management

First-Line Treatments:

- Surgery: Primary treatment for resectable tumors. - Radiation Therapy: Often used preoperatively or postoperatively, especially for unresectable cases.

Adjunctive Therapies:

- Radiofrequency Ablation (RFA): Effective for pain palliation in unresectable tumors, showing trends towards reduced pain severity and interference over time. (Evidence: Moderate) 3 - Trans-arterial (Chemo)embolization: Utilized in specific cases to achieve tumor necrosis and symptom relief. 1 - Chemical, Thermal, and Non-thermal Ablative Therapies: Employed via interventional radiology for symptom management in benign but symptomatic cases, though primarily discussed in benign contexts. 1

Special Populations

Elderly Patients: May benefit from minimally invasive techniques like RFA for pain management due to reduced operative risks. (Evidence: Moderate) 3

Comorbidities: Patients with significant comorbidities may prefer RFA or other interventional radiology approaches over surgery due to lower complication profiles. 1 3

Key Recommendations

Utilize immunohistochemistry and molecular diagnostics to refine diagnosis of soft tissue neoplasms, especially when morphology is ambiguous. (Evidence: Strong) 2

Consider radiofrequency ablation as a viable option for pain palliation in patients with unresectable soft tissue neoplasms, particularly those unsuitable for conventional surgical interventions. (Evidence: Moderate) 3

Employ adjunct interventional radiology techniques, including trans-arterial (chemo)embolization, to enhance treatment efficacy and manage complications in selected cases. (Evidence: Weak) 1

References

1 Filippiadis D, Petsatodis E, Charalampopoulos G, Giannakis A, Chlorogiannis DD, Velonakis G et al.. Benign Soft Tissue Lesions Responsible for Pain: When and How Should the IR Intervene. Cardiovascular and interventional radiology 2025. link 2 Mourtzoukou D, Fisher C, Thway K. Evaluation of Molecular and Immunohistochemical Adjunct Modalities in the Diagnosis of Soft Tissue Neoplasms. International journal of surgical pathology 2015. link 3 Locklin JK, Mannes A, Berger A, Wood BJ. Palliation of soft tissue cancer pain with radiofrequency ablation. The journal of supportive oncology 2004. link

Malignant neoplasm of soft tissue